Symbol
| CPM
| contributors: mct - updated : 24-04-2020
|
HGNC name
| carboxypeptidase M
|
HGNC id
| 2311
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in several tumor tissues | tumoral
|  
|  
| --over
|  
|
in renal clear cell carcinomas | tumoral
|  
| amplification
|  
|  
|
in well-differentiated liposarcomas/atypical lipomatous tumor  | |
Susceptibility
|
to silicosis |
Variant & Polymorphism
other
| rs12812500 variant of the CPM gene may increase silicosis susceptibility  |
|
|
Candidate gene
Marker
| CPM is a novel marker in lipid uptake and/or metabolism of activated macrophages (MAs) by promoting foam cell formation  | |
identification of CPM amplification could be used as an alternative diagnostic tool for the diagnosis of well-differentiated liposarcoma/atypical lipomatous tumors  | Therapy target
|
System | Type | Disorder | Pubmed |
diabete | type 2 | |  |
therapeutic target in insulin resistance |
| | |